EGFR and glioma: Secondly, the molecular detection information was not complete and did not include 1p/19q co-deletion, ATRX mutation, EGFR amplification, etc., but this molecular information was of great significance to the diagnosis and treatment of glioma, so it needs to be improved in future research.